Author | David A. Reardon, MD | OncLive

Author | David A. Reardon, MD

Articles

Dr. Reardon on the Immunogenicity of Glioblastoma

May 31, 2019

Video

David A. Reardon, MD, clinical director, Center for Neuro-Oncology, institute physician, Dana-Farber Cancer Institute, and professor of medicine, Harvard Medical School, discusses the immunogenicity of glioblastoma.

Dr. Reardon on Efficacy/Safety of Immunotherapy Combination in Glioblastoma

August 31, 2018

Video

David A. Reardon, MD, clinical director, Center for Neuro-Oncology, Dana-Farber Cancer Institute, discusses the safety and efficacy data of an immunotherapy combination in glioblastoma.

Dr. Reardon on a Personalized Neoantigen-Targeting Vaccine for GBM

August 29, 2018

Video

David A. Reardon, MD, clinical director, Center for Neuro-Oncology, Dana-Farber Cancer Institute, discusses a personalized neoantigen-targeting vaccine for patients with glioblastoma.

Dr. Reardon on Pembrolizumab and Bevacizumab for Glioblastoma

July 23, 2018

Video

David A. Reardon, MD, clinical director, Center for Neuro-Oncology, Dana-Farber Cancer Institute, discusses pembrolizumab (Keytruda) and bevacizumab (Avastin) for the treatment of patients with recurrent PD-L1–positive glioblastoma.

x